Hereditary late-onset Parkinson disease

Get in touch with RARE Concierge.

Contact RARE Concierge

Hereditary late-onset Parkinson disease

Synonyms: Autosomal dominant late-onset Parkinson disease | LOPD

Hereditary late-onset Parkinson disease (LOPD) is a form of Parkinson disease (PD) characterized by an age of onset of more than 50 years tremor at rest gait complaints and falls bradykinesia rigidity and painful cramps. Patients usually present a low risk of developing non motor symptoms dystonia dyskinesia and levodopa-induced dyskinesia (LID).

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http: // Data version October 2023.

Newly diagnosed with
Hereditary late-onset Parkinson disease?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Genetic Support Network of Victoria

The Genetic Support Network of Victoria is an organisation that supports people living with genetic, undiagnosed and rare conditions and those who support them including community and families, patient support organisations, health professionals and industry. Our vision is our community flourishing and living their best lives.

The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. We currently manage more than 80 disease programs, each of which covers all FDA-approved treatment for the disease named in the program. Since 2009, TAF has helped nearly 180,000 people access critical treatment for life-threatening, chronic, and rare diseases.

Clinical Trials

For a list of clinical trials in this disease area, please click here.